ORCID as entered in ROS
https://orcid.org/0000-0002-5675-1810
Select Publications
Conference Papers
, 2020, 'Selective internal radiation therapy for hepatocellular carcinoma in Australia: A 15-year multicenter cohort study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 46 - 46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2020, 'Underlying non-alcoholic fatty liver disease increases the risk of hepatocellular carcinoma recurrence after curative hepatic resection', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 62 - 63, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'High rates of sustained virological response at 12 weeks in a real-world hospital-based cohort of direct-acting antiviral-treated patients with hepatitis C virus (HCV): The Observational, Prospective Epidemiological Registry in Australia of HCV (OPERA-C)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 79 - 79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'How to manage pemphigus with pre-existing hepatitis B who needs rituximab therapy', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 31 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000467967200098&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'Burden of disease in patients with advanced cirrhosis not suitable for transplant', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 81 - 81, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800137&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'Response to mycophenolate mofetil in patients with autoimmune hepatitis who fail standard therapy is predicted by serum gammaglobulin levels but not by cirrhosis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 59 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800100&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'An Observational, Prospective Epidemiological Registry in Australia of HCV Liver Disease (OPERA-C)', in HEPATOLOGY, WILEY, DC, Washington, pp. 528A - 528A, presented at
, 2017, 'High rates of undiagnosed viral hepatitis and chronic liver disease in the community: A community-based study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 92 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100168&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Impact of a multidisciplinary team on surgical outcomes for patients undergoing curative surgery for hepatocellular carcinoma: A single-center experience', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 113 - 114, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100207&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Very high real-world efficacy of ritonavir boosted paritaprevir with ombitasvir and dasabuvir plus /- ribavirin in hepatitis C genotype 1 in patients with advanced fibrosis -Final results of the REV1TAL study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S521 - S521, presented at
, 2016, 'Excellent SVR12 rates with Viekira Pak in a real-world cohort of HCV Genotype 1 patients predominantly with cirrhosis - the Australian REV1TAL Study', in HEPATOLOGY, WILEY, MA, Boston, pp. 483A - 484A, presented at
, 2016, 'Frequency and severity of biochemical abnormalities with paritaprevir/ritonavir/ombitasvir +/- ribavirin in a real-world cohort of HCV Genotype 1 patients - predictors and clinical significance', in HEPATOLOGY, WILEY, MA, Boston, pp. 442A - 442A, presented at
, 2016, 'Mycophenolate Mofetil in Autoimmune Hepatitis Patients not Responsive or Intolerant to Standard Therapy: the Australian TAPESTRY study', in HEPATOLOGY, WILEY, MA, Boston, pp. 817A - 817A, presented at
, 2016, 'Sofosbuvir plus Peginterferon plus Ribavirin for 12 Weeks in Genotype 3 HCV Infected Patients and Treatment-Experienced Cirrhotic Patients with Genotype 2 HCV Who Did Not Achieve SVR after 16 or 24 Weeks of Sofosbuvir plus Ribavirin', in HEPATOLOGY, WILEY, MA, Boston, pp. 455A - 456A, presented at
, 2016, 'Excellent SVR12 rates with Viekira Pak in a real-world cohort of HCV genotype 1 patients predominantly with cirrhosis - the Australian REV1TAL study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 77 - 78, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700139&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Frequency and severity of hyperbilirubinaemia with Viekira Pak in a real-world cohort of HCV genotype 1 patients - Predictors and clinical significance', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 78 - 79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700140&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Mycophenolate in autoimmune hepatitis not responsive or intolerant to standard therapy: the TAPESTRY study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 100 - 101, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700177&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'C-SCAPE: EFFICACY AND SAFETY OF 12 WEEKS OF GRAZOPREVIR plus /- ELBASVIR plus /- RIBAVIRIN IN PATIENTS WITH HCV GT2, 4, 5 OR 6 INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, AUSTRIA, Vienna, pp. S619 - S619, presented at
, 2014, 'Effect of metabolic syndrome on patients with viral hepatitis treated with local regional therapy for hepatocellular carcinoma', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 806A - 806A, presented at
, 2014, 'Factors associated with medication adherence in patients living with cirrhosis', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 334A - 334A, presented at
, 2014, 'The Protease Fibroblast Activation Protein (FAP) in Liver Disease', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 592A - 592A, presented at
, 2014, 'Effect of metabolic syndrome on patients with viral hepatitis treated with local regional therapy for hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 78 - 78, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'The protease fibroblast activation protein (FAP) in liver disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 6 - 6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'P427 POTENTIAL IMPACT OF IMPROVED TREATMENT ON DISEASE BURDEN OF CHRONIC HEPATITIS C IN AUSTRALIA', in Journal of Hepatology, Elsevier, ENGLAND, London, pp. s210, presented at
, 2013, 'Impaired T cell glucose metabolism during chronic hepatitis C virus infection', in Narci T (ed.), Journal of Gastroenterology and Hepatology, Wiley Online, Melbourne, Australia, pp. 171 - 171, presented at
, 2012, 'Hepatocellular Carcinoma Risk In Chronic Hepatitis B Patients Achieving Viral Suppression With Antiviral Therapy', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 354A - 354A, presented at
, 2012, 'HEPATITIS C VIRUS-SPECIFIC EFFECTOR AND REGULATORY CD4+T CELLS IN PRIMARY INFECTION RESULTING IN CLEARANCE OR CHRONIC INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, SPAIN, Barcelona, pp. S317 - S317, presented at
, 2012, 'IMPAIRED T-CELL GLUCOSE METABOLISM DURING CHRONIC HEPATITIS C VIRUS INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, SPAIN, Barcelona, pp. S302 - S302, presented at
, 2012, 'T CELLS CO-EXPRESSING CCR2, CCR5, CXCR3, AND CXCR6 ARE PREFERENTIALLY ENRICHED IN THE HCV-INFECTED LIVER', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, SPAIN, Barcelona, pp. S313 - S313, presented at
, 2010, 'HEPATIC MICRORNA 135A*REGULATES HEPATIC TRIGLYCERIDE STORAGE AND IS REPRESSED DURING HCV INFECTION', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 727A - 727A, presented at
, 2010, 'SERUM PROTEOMIC PROFILES ASSOCIATED WITH IL28B GENOTYPE AMONG CHC PATIENTS', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 727A - 728A, presented at
, 2009, 'HEPATIC MICRORNAS EXPRESSION IN OBESE SUBJECTS WITH CHRONIC HCV', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 940A - 940A, presented at
, 2009, 'RELATIONSHIP OF RETINOL BINDING PROTEIN-4 WITH LIVER INJURY IN MORBIDLY OBESE SUBJECTS', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 789A - 789A, presented at
, 2009, 'STATINS AND LIVER INJURY IN MORBIDLY OBESE SUBJECTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 789A - 789A, presented at
, 2009, 'THE MICRORNA MIR-923 IS HIGHLY ABUNDANT AND DIFFERENTIALLY EXPRESSED BETWEEN NORMAL AND FATTY LIVERS', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 1185A - 1185A, presented at
, 2008, 'EFFECT OF OBESITY ON INTERFERON STIMULATED GENES EXPRESSION IN CHRONIC HCV INFECTION', in HEPATOLOGY, JOHN WILEY & SONS INC, CA, San Francisco, pp. 864A - 865A, presented at
, 2008, 'EFFECT OF STEATOSIS ON THE INTRAHEPATIC CYTOKINE/CHEMOKINE RESPONSES IN CHRONIC HCV', in HEPATOLOGY, JOHN WILEY & SONS INC, CA, San Francisco, pp. 789A - 789A, presented at
, 2008, 'Clinical characteristics of patients with hepatocellular carcinoma presenting to a single tertiary institute', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A279 - A279, presented at
, 2008, 'Differential expression of interferon stimulating genes in obese subjects receiving treatment for chronic hepatitis C', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A282 - A282, presented at
, 2008, 'EFFECT OF OBESITY ON INTERFERON STIMULATED GENES EXPRESSION IN CHRONIC HCV INFECTION', in Hepatology, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. 1248 - 1249, presented at
, 2008, 'Effect of obesity on the intrahepatic cytokine/chemokine responses in chronic hepatitis C', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A285 - A285, presented at
, 2008, 'EFFECT OF STEATOSIS ON THE INTRAHEPATIC CYTOKINE/CHEMOKINE RESPONSES IN CHRONIC HCV', in Hepatology, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. 1080 - 1081, presented at
, 2008, 'High retinol binding protein-4 and low adiponectin levels are associated with steatosis in bariatric patients', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A285 - A285, presented at
, 2008, 'Preparedness for candidate hepatitis C vaccine trials in people who inject drugs: challenges and opportunities', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A358 - A358
, 2008, 'Statins may aggravate liver injury in obese subjects with nonalcoholic fatty liver disease', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A283 - A283, presented at
, 2007, 'Polymorphisms in adrenergic receptors, adiponcetin and adiponectin receptors influence fibrosis rates and response to therapy in chronic HCV', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 440A - 440A, presented at
Conference Posters
, 2014, 'Factors associated with medication adherence in patients living with cirrhosis', Boston, presented at American Association Society for Liver Disease (AASLD) Liver meeting, Boston, 07 November 2014 - 10 November 2014
Conference Abstracts
, 2022, 'MONITORING QUALITY OF CARE IN HEPATOCELLULAR CARCINOMA: A MODIFIED DELPHI CONSENSUS', in HEPATOLOGY, WILEY, Vol. 76, pp. S1311 - S1312, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000870796604144&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'EFFECT OF GUT INFLUENCE ON THE IMMUNE ENVIRONMENT IN PRE-CLINICAL HCC', in GUT, BMJ PUBLISHING GROUP, Vol. 71, pp. A5 - A5, http://dx.doi.org/10.1136/gutjnl-2022-IDDF.6
, 2022, 'Effect of gut influence on the immune environment in preclinical hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 37, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852585700071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Filter by type
https://orcid.org/0000-0002-5675-1810